Reversible Pulmonary Hypertension in an Infant Treated with Diazoxide
Background: Diazoxide is the main therapeutic agent for congenital hyperinsulinism. The drug is generally well tolerated; however, in this report severe adverse effects including heart failure (HF) and pulmonary hypertension (PH) in an infant are reported.Case report: A sixteen-day male infant with...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Mashhad University of Medical Sciences
2014-06-01
|
| Rangatū: | Asia Pacific Journal of Medical Toxicology |
| Ngā marau: | |
| Urunga tuihono: | http://apjmt.mums.ac.ir/pdf_3049_545e9ed2bbabfbd536377783032195ce.html |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|